Etanercept and efalizumab for the treatment of adults with psoriasis

Review decision - September 2010 information

Appendix A: Decision paper presented to the Institute's Guidance Executive (PDF 105 KB)

Review proposal - August 2010 information

Appendix A: provisional matrix of stakeholders (PDF 29 KB)

Appendix B: proposal paper presented to the Institute's Guidance Executive (PDF 285 KB)

Review decision - July 2009 information

Review decision - December 2008 information

Review decision - December 2008: table of comments (PDF 43 KB)

Review decision - December 2008: table of comments (PDF 43 KB)

Review proposal - October 2008 information

Provisional matrix of consultees and commentators (MSWord 67 KB)

Appeal outcome information

Appeal outcome: Decision of the panel (PDF 52 KB)

Post-appeal final appraisal determination: Psoriasis - efalizumab and etanercept information

Post-appeal final appraisal determination: Psoriasis - efalizumab and etanercept (PDF 175 KB)

Appeal details: Efalizumab and etanercept for psoriasis information

Details of appeal announced information

Final Appraisal Determination: Psoriasis - efalizumab and etanercept information

Final Appraisal Determination: Efalizumab and etanercept for the treatment of adults with psoriasis (PDF 183 KB)

ACD tabulation of contents (PDF 346 KB)

Addendum following price change for infliximab (PDF 87 KB)

Addendum - additional analysis (PDF 322 KB)

Sensitivity analysis - Aug 05 (PDF 66 KB)

Appeal announcement information

Appraisal Consultation Document: Psoriasis - efalizumab and etanercept information

Psoriasis - efalizumab and etanercept: assessment report (PDF 1.34 MB)

Economic addendum (1) (PDF 220 KB)

Economic addendum (2) (PDF 159 KB)

NICE technology appraisal: New treatments for moderate to severe psoriasis  information

Efalizumab and etanercept for the treatment of psoriasis - Final protocol (PDF 156 KB)

Archive: Efalizumab and etanercept for the treatment of psoriasis - Final Scope (PDF 81 KB)

Archive: Efalizumab and etanercept for the treatment of psoriasis - Final Scope (PDF 81 KB)

2003/009 NICE asked to develop guidance on treating eczema, support programmes for parents dealing with conduct disorder in children, use of statins for heart disease, and when hysterectomy is appropriate information

2003/009 NICE asked to develop guidance on treating eczema, support programmes for parents dealing with conduct disorder in children, use of statins for heart disease, and when hysterectomy is appropriate (PDF 101 KB)